Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval
The Next Advance in Durable Polymer Stent Technology from Boston Scientific is Now Available in Europe and Other Select Geographies NATICK, Mass. - Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System, the company's next-generation durable polymer drug-eluting stent (DES) technology, and is...
Read More »Boston Scientific Receives CE Mark for TAXUS-® Liberte(TM) Long Stent
Longest drug-eluting stent approved for the management of patients with clinically challenging coronary artery disease NATICK, Mass., and BARCELONA, Spain, May 24 /- Boston Scientific Corporation (NYSE:BSX) today announced that it has received CE Mark for its TAXUS-® Liberte(TM) Long paclitaxel-eluting coronary stent system, allowing doctors to treat longer coronary artery lesions with a single...
Read More »Angiotech's Corporate Partner, Boston Scientific, Announces Japanese Launch of TAXUS-® Express2(TM) Coronary Stent System
Reimbursement granted by National Health Insurance System VANCOUVER, May 8 // -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI)(NASDAQ:TSX:)(NASDAQ:ANP), a global specialty pharmaceutical and medical device company, along with its corporate partner Boston Scientific Corporation (NYSE: BSX) today announced the launch of its TAXUS(R) Express2(TM) paclitaxel-eluting coronary stent system in Japan....
Read More »New Device Granted Humanitarian Exemption to Treat Intracranial Aneurysms
CORDIS ENTERPRISE(TM) Vascular Reconstruction Device and Delivery System Receives HDE Approval from U.S. Food and Drug Administration MIAMI LAKES, Fla., May 9 -- Cordis Neurovascular, Inc. announced today that the U.S. Food and Drug Administration has granted Humanitarian Device Exemption (HDE) approval for the CORDIS ENTERPRISE(TM) Vascular Reconstruction Device and Delivery System for use with...
Read More »
The Real Cost of Falls and Other Workplace Injuries
When it comes to workplace falls and accidents: inattention to problematic situations and the lack of an appropriate safety plan will cost you on multiple fronts. Our guide covers all the areas of concern to make sure you're protected against risk.
Read More »Boston Scientific Becomes only Company with Two Drug-Eluting Stent Platforms with European Approval of Everolimus-Eluting PROMUS(TM) Stent System
PROMUS stent to complement Company's market-leading TAXUS-® stent systems NATICK, Mass., Oct. 16 // -- Boston Scientific Corporation (NYSE:BSX) announced today that the PROMUS(TM) Everolimus-Eluting Coronary Stent System has received CE Mark approval, making Boston Scientific the only company to offer two distinct approved drug-eluting stent (DES) platforms in the CE geographies. This approval...
Read More »First Hospital Nationwide Now Offers Less-Invasive Procedure for Select Patients with Obstructed Neck Arteries
Ochsner Health System in New Orleans Conducts First Carotid Procedure with Newly-Approved Stent System NEW ORLEANS, Oct. 9 -- The Ochsner Health System in New Orleans, Louisiana, conducted the first patient procedure involving the new, FDA-approved PRECISEÃ-® Nitinol Stent and ANGIOGUARDÃ-® Emboli Capture Guidewire carotid system. The new devices, marketed by Cordis Endovascular, a...
Read More »Abbott Begins Early International Launch of XIENCE(TM) V Everolimus Eluting Coronary Stent System
Company Expects to Achieve a Leadership Position in Drug-Eluting Stent Market with XIENCE V ABBOTT PARK, Ill., Oct. 3 / - Abbott (NYSE:ABT) today announced that it has begun the international launch of the XIENCE(TM) V Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease earlier than the company's original projections. The XIENCE V stent system will be launched in...
Read More »Drug-Eluting Stent promotes smooth procedures.
CYPHER SELECT(TM) Plus Stent carries CE mark and is designed to help interventional cardiologists reach and treat coronary artery blockages. In addition to flexible stent design and short tip, delivery system features lubricious CYPH2ONIC(TM) Hydrophilic Coating Technology to facilitate delivery of stent even when lesion is located in tortuous blood vessel.
Read More »Abbott Announces European Launch of Next-Generation Device Designed to Treat Patients at Risk of Stroke
Filter-Based Embolic Protection System Provides Advanced Treatment for Patients Undergoing a Carotid Stenting Procedure ABBOTT PARK, Ill., Sept. 13 -- Abbott (NYSE:ABT) announced today CE Mark approval and European launch of the company's next- generation embolic protection device, the Emboshield(R) PRO Embolic Protection System. Embolic protection devices are designed to capture and remove...
Read More »PROMUS(TM) Everolimus-Eluting Stent Added to Boston Scientific Coronary Stent Portfolio
PROMUS Stent joins market-leading TAXUS-® Paclitaxel-Eluting Coronary Stent Systems NATICK, Mass., Sept. 1//-- Boston Scientific Corporation (NYSE:BSX) today announced plans for the anticipated International launch of its PROMUS(TM)(1) Everolimus-Eluting Coronary Stent System. The addition of the PROMUS Stent will expand the Company's drug- eluting stent (DES) portfolio to include two distinct...
Read More »
Precision Fabricating with Over 40 Years of Experience
Quality Sheet Metal specializes in delivering precision, value, and customer service. With a client base that spans many diverse industries and a reputation for excellence that goes back over four decades, our clients know that we can provide the optimal combination of value and flexibility regardless of the challenge. See our video to learn what we can do for you. Through investments in state-of-the-art design, manufacturing, and quality control systems, Quality Sheet Metal remains focused on maintaining a high standard of quality, customer service, and competitive pricing. With an emphasis on customer satisfaction, Quality Sheet Metal is dedicated to establishing long-term partnerships, similar to the ones they currently have with their valued clients. If you're looking for a new partner with extensive capabilities in sheet metal fabricating and finishing, look no further.
Read More »
